{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladie gravidique précoce : Questions médicales les plus fréquentes",
"headline": "Maladie gravidique précoce : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladie gravidique précoce : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladie gravidique précoce"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Vomissement",
"url": "https://questionsmedicales.fr/mesh/D014839",
"about": {
"@type": "MedicalCondition",
"name": "Vomissement",
"code": {
"@type": "MedicalCode",
"code": "D014839",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.937"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hyperémèse gravidique",
"alternateName": "Hyperemesis Gravidarum",
"url": "https://questionsmedicales.fr/mesh/D006939",
"about": {
"@type": "MedicalCondition",
"name": "Hyperémèse gravidique",
"code": {
"@type": "MedicalCode",
"code": "D006939",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.821.937.049.500"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladie gravidique précoce",
"alternateName": "Morning Sickness",
"code": {
"@type": "MedicalCode",
"code": "D048968",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Dae Yul Kim",
"url": "https://questionsmedicales.fr/author/Dae%20Yul%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "Min Ho Chun",
"url": "https://questionsmedicales.fr/author/Min%20Ho%20Chun",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "JaYoung Kim",
"url": "https://questionsmedicales.fr/author/JaYoung%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea."
}
},
{
"@type": "Person",
"name": "T Requena",
"url": "https://questionsmedicales.fr/author/T%20Requena",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biotecnología y Microbiología de Alimentos, Instituto de Investigación en Ciencias de la Alimentación (CIAL-CSIC), Madrid, España. Electronic address: t.requena@csic.es."
}
},
{
"@type": "Person",
"name": "M Velasco",
"url": "https://questionsmedicales.fr/author/M%20Velasco",
"affiliation": {
"@type": "Organization",
"name": "Sección de Enfermedades Infecciosas, Medicina Interna, Hospital Universitario Fundación Alcorcón, Alcorcón, España."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer.",
"datePublished": "2024-04-29",
"url": "https://questionsmedicales.fr/article/38682731",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/sju.v59.34015"
}
},
{
"@type": "ScholarlyArticle",
"name": "5-alpha reductase inhibitors and MRI prostates: actively reducing prostate sizes and ambiguity.",
"datePublished": "2023-04-15",
"url": "https://questionsmedicales.fr/article/37061671",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12894-023-01235-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Morphologic spectrum of treatment-related changes in prostate tissue and prostate cancer: an updated review.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35716730",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.humpath.2022.06.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Detection rate and variables associated with incidental prostate cancer by holmium laser enucleation of the prostate.",
"datePublished": "2022-05-18",
"url": "https://questionsmedicales.fr/article/35584916",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/iju.14917"
}
},
{
"@type": "ScholarlyArticle",
"name": "CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer.",
"datePublished": "2022-12-09",
"url": "https://questionsmedicales.fr/article/36493335",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1200/JCO.22.01453"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Signes et symptômes digestifs",
"item": "https://questionsmedicales.fr/mesh/D012817"
},
{
"@type": "ListItem",
"position": 5,
"name": "Vomissement",
"item": "https://questionsmedicales.fr/mesh/D014839"
},
{
"@type": "ListItem",
"position": 6,
"name": "Maladie gravidique précoce",
"item": "https://questionsmedicales.fr/mesh/D048968"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladie gravidique précoce - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladie gravidique précoce",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladie gravidique précoce",
"description": "Comment diagnostiquer la maladie gravidique précoce ?\nQuels examens sont nécessaires pour le diagnostic ?\nQuand consulter un médecin pour des nausées ?\nLes nausées matinales sont-elles normales ?\nPeut-on confondre avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=6#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladie gravidique précoce",
"description": "Quels sont les symptômes typiques ?\nLes symptômes varient-ils d'une femme à l'autre ?\nLes nausées surviennent-elles à tout moment ?\nY a-t-il des symptômes associés ?\nLes vomissements sont-ils fréquents ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=6#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladie gravidique précoce",
"description": "Peut-on prévenir les nausées matinales ?\nQuels aliments éviter pour réduire les symptômes ?\nLe stress influence-t-il les nausées ?\nL'hydratation aide-t-elle à prévenir les nausées ?\nLes vitamines peuvent-elles aider ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=6#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladie gravidique précoce",
"description": "Quels traitements sont disponibles ?\nLes remèdes naturels sont-ils efficaces ?\nQuand utiliser des médicaments ?\nY a-t-il des effets secondaires aux traitements ?\nLes traitements sont-ils sûrs pendant la grossesse ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=6#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladie gravidique précoce",
"description": "Quelles complications peuvent survenir ?\nComment reconnaître une complication ?\nLes complications affectent-elles le bébé ?\nQuelles sont les conséquences d'une déshydratation ?\nL'hyperémèse gravidique est-elle fréquente ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=6#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladie gravidique précoce",
"description": "Quels sont les facteurs de risque connus ?\nL'âge de la mère influence-t-il les nausées ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?\nLes femmes fumeuses sont-elles plus à risque ?",
"url": "https://questionsmedicales.fr/mesh/D048968?mesh_terms=Prostatic+Neoplasms&page=6#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la maladie gravidique précoce ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes rapportés par la patiente et l'exclusion d'autres causes."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Aucun examen spécifique n'est requis, mais des analyses sanguines peuvent être faites si nécessaire."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin pour des nausées ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter si les nausées sont sévères ou persistent au-delà du premier trimestre."
}
},
{
"@type": "Question",
"name": "Les nausées matinales sont-elles normales ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont fréquentes et généralement considérées comme normales durant la grossesse."
}
},
{
"@type": "Question",
"name": "Peut-on confondre avec d'autres maladies ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est important d'exclure d'autres causes comme des infections ou des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, vomissements, fatigue et hypersensibilité aux odeurs."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une femme à l'autre ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les femmes."
}
},
{
"@type": "Question",
"name": "Les nausées surviennent-elles à tout moment ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que souvent matinales, les nausées peuvent survenir à tout moment de la journée."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des maux de tête ou des changements d'humeur peuvent également apparaître."
}
},
{
"@type": "Question",
"name": "Les vomissements sont-ils fréquents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vomissements peuvent survenir chez certaines femmes, mais ne sont pas systématiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les nausées matinales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode garantie, mais des changements alimentaires peuvent aider."
}
},
{
"@type": "Question",
"name": "Quels aliments éviter pour réduire les symptômes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les aliments gras, épicés et les odeurs fortes qui peuvent aggraver les nausées."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les nausées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes, il est donc conseillé de pratiquer des techniques de relaxation."
}
},
{
"@type": "Question",
"name": "L'hydratation aide-t-elle à prévenir les nausées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, rester bien hydraté peut aider à réduire l'intensité des nausées."
}
},
{
"@type": "Question",
"name": "Les vitamines peuvent-elles aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vitamines, comme la vitamine B6, peuvent aider à réduire les symptômes chez certaines femmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des changements alimentaires, des médicaments anti-nauséeux et l'hydratation."
}
},
{
"@type": "Question",
"name": "Les remèdes naturels sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des remèdes comme le gingembre ou les tisanes peuvent aider à soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand utiliser des médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médicaments sont recommandés si les symptômes sont sévères et affectent la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires aux traitements ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent avoir des effets secondaires, il est donc important de consulter."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils sûrs pendant la grossesse ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La plupart des traitements sont considérés comme sûrs, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la déshydratation ou l'hyperémèse gravidique peuvent survenir dans les cas graves."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une complication ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des vomissements fréquents, une perte de poids ou des douleurs abdominales nécessitent une consultation."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles le bébé ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans les cas graves, des complications peuvent affecter la santé du bébé, d'où l'importance d'un suivi médical."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une déshydratation ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation peut entraîner des complications graves, y compris des problèmes rénaux et des déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "L'hyperémèse gravidique est-elle fréquente ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'hyperémèse gravidique est rare mais nécessite une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents de nausées dans des grossesses précédentes et des grossesses multiples."
}
},
{
"@type": "Question",
"name": "L'âge de la mère influence-t-il les nausées ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes plus jeunes, notamment celles de moins de 20 ans, peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial de nausées matinales peut augmenter le risque chez la mère."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress émotionnel et physique peut augmenter la probabilité de développer des nausées."
}
},
{
"@type": "Question",
"name": "Les femmes fumeuses sont-elles plus à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut influencer l'intensité des nausées matinales chez certaines femmes."
}
}
]
}
]
}
Changes in work-up and histopathological assessment have caused stage and grade migration in men with prostate cancer (PCa). The aim of this study was to assess temporal trends in risk of PCa death fo...
Men aged 75 or younger with Charlson Comorbidity index 0-1 diagnosed with favourable-risk PCa (T1-T2, prostate specific antigen [PSA] <20 ng/mL and Gleason score 6 or 7[3+4]) in the period 2000-2016 w...
A total of 9,666 men were selected for each treatment strategy. The 7-year cumulative incidence of PCa death decreased in all risk and treatment groups. For example, the incidence in men diagnosed wit...
Men diagnosed in 2011-2016 with low-risk and favourable intermediate-risk PCa have a similar relative benefit but smaller absolute benefit of curative treatment compared to men diagnosed in 2000-2005....
Magnetic resonance imaging (MRI) scans are increasingly first-line investigations for suspected prostate cancer, and essential in the decision for biopsy. 5-alpha reductase inhibitor (5-ARI) use has b...
From 2015 to 2020, we collected retrospective data of consecutive patients undergoing prostate biopsy at one centre. We included patients who were biopsy-naïve, had prior negative biopsies, or on acti...
351 men underwent saturation biopsy with or without targeted biopsies. 54 (15.3%) had a history of 5-ARI use. On mpMRI, there was no significant difference between the 5ARI and non-5-ARI groups in PIR...
Our study found significant differences in biochemical, imaging and biopsy characteristics between 5-ARI and non-5-ARI groups. While both groups had similar PIRADS distribution, 5-ARI patients had a l...
A wide range of treatment options are available to patients with prostate cancer. Some treatments are standard (currently used) while some are emerging therapies. Androgen deprivation therapy is typic...
Holmium laser enucleation of the prostate is well-established and effective for bladder outlet obstruction due to benign prostatic hyperplasia. The objective of this study was to examine the detection...
A total of 612 patients were enrolled. We retrospectively examined the detection rate of incidental prostate cancer and perioperative variables associated with them....
Forty-nine of 612 patients were diagnosed with incidental prostate cancer. Univariate logistic regression analysis showed that higher prostate-specific antigen density (odds ratio 3.34, 95% confidence...
The detection rate of incidental prostate cancer was 8.0%, and findings of the prostate cancer on magnetic resonance imaging were an independent predictive factor for incidental prostate cancer....
Prostate cancer (PCa) is highly heritable. No validated PCa risk model currently exists. We therefore sought to develop a genetic risk model that can provide personalized predicted PCa risks on the ba...
We developed a risk model using a kin-cohort comprising individuals from 16,633 PCa families ascertained in the United Kingdom from 1993 to 2017 from the UK Genetic Prostate Cancer Study, and complex ...
The most parsimonious model included the effects of pathogenic variants in...
To our knowledge, this is the first validated risk model offering personalized PCa risks. The model will assist in counseling men concerned about their risk and can facilitate future risk-stratified p...
Reducing low-value clinical care is an important strategy to mitigate environmental pollution caused by health care....
To estimate the environmental impacts associated with prostate magnetic resonance imaging (MRI) and prostate biopsy....
We performed a cradle-to-grave life cycle assessment of prostate biopsy. Data included materials and energy inventory, patient and staff travel contributed by prostate MRI, transrectal ultrasound guid...
Greenhouse gas emissions (CO...
In the USA, a single transrectal prostate biopsy procedure including prostate MRI, and targeted and systematic biopsies emits an estimated 80.7 kg CO...
A prostate biopsy contributes a calculable environmental footprint. Modifying or reducing the number of biopsies performed through existing evidence-based approaches would decrease health care polluti...
We estimated that prostate magnetic resonance imaging (MRI) with a prostate biopsy procedure emits the equivalent of 80.7 kg of carbon dioxide. Performing fewer unnecessary prostate biopsies or using ...
A family history (FH) of prostate cancer (PrCa) is associated with an increased likelihood of PrCa diagnosis. Conflicting evidence exists regarding familial PrCa and clinical outcomes among PrCa patie...
To determine how the number, degree, and age of a PrCa patient's affected relatives are associated with OS and PCSS of those already diagnosed with PrCa....
The UK Genetic Prostate Cancer Study is a longitudinal, multi-institutional, observational study collecting baseline and follow-up clinical data since 1992. We examined OS and PCSS in 16340 men by deg...
The primary outcome was all-cause mortality among PrCa patients. The risk of death with respect to FH was assessed by calculating hazard ratios from Cox proportional hazard regression models, adjustin...
A stronger FH was inversely associated with the risk of all-cause and PrCa-specific mortality. This association was greater in those with an increasing number (p-trend < 0.001) and increasing closenes...
Based on the investigation of the type and timing of relatives' cancers, it is likely that reductions in mortality are due almost completely to a greater awareness of the disease. This study provides ...
We were interested in how a family history of prostate cancer affects survival in prostate cancer patients. We studied 16340 patients, categorised them according to the strength of their family histor...
Assess radiologists' contribution to variation in clinically significant prostate cancer (csPCa) detection in patients with elevated prostate-specific antigen (PSA) and multiparametric MRI (mpMRI)....
This institutional review board-approved, retrospective cohort study was performed at a tertiary, academic, National Cancer Institute-designated Comprehensive Cancer Center with a multidisciplinary pr...
Study cohort included 960 MRIs in 928 men, mean age 64.0 years (SD ± 7.4), and 59.8% (555 of 928) had csPCa. Interpreting radiologist was not significant individually (P > .999) or combined with mpMRI...
Although there is known in-practice variation in radiologists' interpretation of mpMRI, in our multidisciplinary prostate cancer program we found no significant radiologist-attributable variation in c...
Recent data have found an overall survival benefit from prostate-directed radiotherapy in patients with low-volume metastatic prostate cancer. Prostate SBRT is an attractive treatment in this setting ...
We reviewed patients with low-volume metastatic disease who received prostate SMART from October 2019 to December 2021 on a 0.35T MR-Linac. The cohort included 14 patients. Genitourinary (GU) and gast...
The median follow-up time was 29 months. Seven patients had hormone sensitive prostate cancer and 7 had castrate resistant prostate cancer (CRPC). 13 patients received 36.25 Gy in 5 fractions and one ...
Prostate SMART was found to be well tolerated and all patients had local control of disease within the prostate at the time of last follow-up. Prostate SMART may represent a low-risk and well-tolerate...
Prostate-specific membrane antigen (PSMA) PET findings of mixed ductal-acinar adenocarcinoma of the prostate are rarely reported. We describe 18 F-PSMA-1007 PET/CT and delayed pelvic 18 F-PSMA-1007 PE...
